3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
23 24 0 0 0 0 0 0 0999 V2000
4.0423 -0.5193 -0.0001 O 0 0 0 0 0 0 0 0 0 0 0 0
2.7213 1.3474 0.0003 O 0 0 0 0 0 0 0 0 0 0 0 0
-0.0703 0.6750 0.0002 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.5240 -1.5008 0.0001 N 0 0 0 0 0 0 0 0 0 0 0 0
1.7842 -0.8092 0.0003 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.4387 0.5865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.6970 -0.7814 -0.0001 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4302 -0.5971 0.0002 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4422 1.5561 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.0297 -1.2268 -0.0001 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7628 1.0951 -0.0002 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.0536 -0.2711 -0.0002 C 0 0 0 0 0 0 0 0 0 0 0 0
2.8355 0.1278 0.0003 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2047 0.3179 -0.0006 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4682 1.5309 0.0003 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.2139 2.6158 0.0001 H 0 0 0 0 0 0 0 0 0 0 0 0
-3.2660 -2.2861 0.0000 H 0 0 0 0 0 0 0 0 0 0 0 0
-4.5779 1.8146 -0.0003 H 0 0 0 0 0 0 0 0 0 0 0 0
-5.0900 -0.5988 -0.0003 H 0 0 0 0 0 0 0 0 0 0 0 0
2.0595 -1.7878 0.0002 H 0 0 0 0 0 0 0 0 0 0 0 0
6.0874 -0.3270 -0.0010 H 1 0 0 0 0 0 0 0 0 0 0 0
5.2238 0.9391 0.8998 H 1 0 0 0 0 0 0 0 0 0 0 0
5.2230 0.9391 -0.9011 H 1 0 0 0 0 0 0 0 0 0 0 0
1 13 1 0 0 0 0
1 14 1 0 0 0 0
2 13 2 0 0 0 0
3 6 1 0 0 0 0
3 8 1 0 0 0 0
3 15 1 0 0 0 0
4 7 1 0 0 0 0
4 8 2 0 0 0 0
5 8 1 0 0 0 0
5 13 1 0 0 0 0
5 20 1 0 0 0 0
6 7 1 0 0 0 0
6 9 2 0 0 0 0
7 10 2 0 0 0 0
9 11 1 0 0 0 0
9 16 1 0 0 0 0
10 12 1 0 0 0 0
10 17 1 0 0 0 0
11 12 2 0 0 0 0
11 18 1 0 0 0 0
12 19 1 0 0 0 0
14 21 1 0 0 0 0
14 22 1 0 0 0 0
14 23 1 0 0 0 0
M ISO 3 21 2 22 2 23 2
4. 国际命名与标识
4.1 IUPAC Name
trideuteriomethyl N-(1H-benzimidazol-2-yl)carbamate
4.2 InChl
InChI=1S/C9H9N3O2/c1-14-9(13)12-8-10-6-4-2-3-5-7(6)11-8/h2-5H,1H3,(H2,10,11,12,13)/i1D3
4.3 InChlKey
TWFZGCMQGLPBSX-FIBGUPNXSA-N
4.4 Canonical SMILES
COC(=O)NC1=NC2=CC=CC=C2N1
4.5 lsomeric SMILES
[2H]C([2H])([2H])OC(=O)NC1=NC2=CC=CC=C2N1
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病